Is mammography for breast cancer screening cost-effective in both western and asian countries? Results of a systematic review

Ki Bong Yoo, Jeoung A. Kwon, Eun Cho, Moon Hae Kang, Jung Mo Nam, Kui Son Choi, Eun Kyung Kim, Yun Jeong Choi, Eun Cheol Park

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries. Materials and Methods: A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost-effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not. Results: We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p<0.0014). Conclusions: Mammography screening is cost-effective in most of Western countries, but not in Asian countries. The reason for this result may be the issues of incidence rate or racial characteristics, such as dense breast tissue. The results indicate that mammography screening should be adopted prudently in Asian countries and other countries with low incidence rates.

Original languageEnglish
Pages (from-to)4141-4149
Number of pages9
JournalAsian Pacific Journal of Cancer Prevention
Volume14
Issue number7
DOIs
Publication statusPublished - 2013

Fingerprint

Mammography
Early Detection of Cancer
Breast Neoplasms
Costs and Cost Analysis
Mass Screening
Incidence
Gross Domestic Product
Cost-Benefit Analysis
Breast
Research

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

@article{75c87e6f6a8c46589444f83085f817bc,
title = "Is mammography for breast cancer screening cost-effective in both western and asian countries?: Results of a systematic review",
abstract = "Background: Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries. Materials and Methods: A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost-effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not. Results: We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p<0.0014). Conclusions: Mammography screening is cost-effective in most of Western countries, but not in Asian countries. The reason for this result may be the issues of incidence rate or racial characteristics, such as dense breast tissue. The results indicate that mammography screening should be adopted prudently in Asian countries and other countries with low incidence rates.",
author = "Yoo, {Ki Bong} and Kwon, {Jeoung A.} and Eun Cho and Kang, {Moon Hae} and Nam, {Jung Mo} and Choi, {Kui Son} and Kim, {Eun Kyung} and Choi, {Yun Jeong} and Park, {Eun Cheol}",
year = "2013",
doi = "10.7314/APJCP.2013.14.7.4141",
language = "English",
volume = "14",
pages = "4141--4149",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "7",

}

Is mammography for breast cancer screening cost-effective in both western and asian countries? Results of a systematic review. / Yoo, Ki Bong; Kwon, Jeoung A.; Cho, Eun; Kang, Moon Hae; Nam, Jung Mo; Choi, Kui Son; Kim, Eun Kyung; Choi, Yun Jeong; Park, Eun Cheol.

In: Asian Pacific Journal of Cancer Prevention, Vol. 14, No. 7, 2013, p. 4141-4149.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Is mammography for breast cancer screening cost-effective in both western and asian countries?

T2 - Results of a systematic review

AU - Yoo, Ki Bong

AU - Kwon, Jeoung A.

AU - Cho, Eun

AU - Kang, Moon Hae

AU - Nam, Jung Mo

AU - Choi, Kui Son

AU - Kim, Eun Kyung

AU - Choi, Yun Jeong

AU - Park, Eun Cheol

PY - 2013

Y1 - 2013

N2 - Background: Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries. Materials and Methods: A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost-effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not. Results: We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p<0.0014). Conclusions: Mammography screening is cost-effective in most of Western countries, but not in Asian countries. The reason for this result may be the issues of incidence rate or racial characteristics, such as dense breast tissue. The results indicate that mammography screening should be adopted prudently in Asian countries and other countries with low incidence rates.

AB - Background: Mammography is considered the gold standard of breast cancer mass screening and many countries have implemented this as an established breast cancer screening strategy. However, although the incidence of breast cancer and racial characteristics are different between Western and Asian countries, many Asian countries adopted mammography for mass screening. Therefore, the objective of this research was to determine whether mammography mass screening is cost-effective for both Western and Asian countries. Materials and Methods: A systematic review was performed of 17 national mammography cost-effectiveness data sets. Per capita gross domestic product (GDP), breast cancer incidence rate, and the most optimal cost-effectiveness results [cost per life year saved (LYS)] of a mammography screening strategy for each data set were extracted. The CE/per capita GDP ratio is used to compare the cost-effectiveness of mammography by countries. Non-parametric regression was used to find a cut-off point which indicated the breast cancer incidence rate boundary line determining whether mammography screening is cost-effective or not. Results: We found that the cost-effective cut-off point of breast cancer incidence rate was 45.04; it exactly divided countries into Western and Asian countries (p<0.0014). Conclusions: Mammography screening is cost-effective in most of Western countries, but not in Asian countries. The reason for this result may be the issues of incidence rate or racial characteristics, such as dense breast tissue. The results indicate that mammography screening should be adopted prudently in Asian countries and other countries with low incidence rates.

UR - http://www.scopus.com/inward/record.url?scp=84885459205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885459205&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2013.14.7.4141

DO - 10.7314/APJCP.2013.14.7.4141

M3 - Article

C2 - 23991967

AN - SCOPUS:84885459205

VL - 14

SP - 4141

EP - 4149

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 7

ER -